UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000018438
Receipt No. R000021349
Official scientific title of the study A nation-wide survey of sclerosing cholangitis in Japan
Date of disclosure of the study information 2015/07/27
Last modified on 2018/02/05 (Ver. 10)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study A nation-wide survey of sclerosing cholangitis in Japan
Title of the study (Brief title) A nation-wide survey of sclerosing cholangitis in Japan
Region
Japan

Condition
Condition sclerosing cholangitis
Classification by specialty
Hepato-biliary-pancreatic medicine
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To survey general features of primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan
Basic objectives2 Others
Basic objectives -Others epidemiological study
Trial characteristics_1 Exploratory
Trial characteristics_2 Others
Developmental phase Not applicable

Assessment
Primary outcomes Number of new cases, clinical features, treatment and prognosis of patients with PSC and IgG4-SC in referral centers in Japan
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Diagnosed as PSC or IgG4-SC
Key exclusion criteria N/A
Target sample size 500

Research contact person
Name of lead principal investigator Atsushi Tanaka
Organization Teikyo University School of Medicine
Division name Dept of Medicine
Address 2-11-1,kaga,Itabashi-ku
TEL 03(3964)1211
Email a-tanaka@med.teikyo-u.ac.jp

Public contact
Name of contact person Atsushi Tanaka
Organization Teikyo University School of Medicine
Division name Dept of Medicine
Address 2-11-1,kaga,Itabashi-ku
TEL 03(3964)1211
Homepage URL
Email a-tanaka@med.teikyo-u.ac.jp

Sponsor
Institute the Intractable Hepato-Biliary Diseases Study Group in Japan
Institute
Department

Funding Source
Organization MHLW
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 07 Month 27 Day

Progress
Recruitment status Completed
Date of protocol fixation
2015 Year 05 Month 27 Day
Anticipated trial start date
2015 Year 07 Month 01 Day
Last follow-up date
2015 Year 09 Month 30 Day
Date of closure to data entry
2015 Year 12 Month 31 Day
Date trial data considered complete
2016 Year 01 Month 31 Day
Date analysis concluded
2016 Year 03 Month 31 Day

Related information
URL releasing protocol
Publication of results Published
URL releasing results
Results
Other related information In this study we will collect clinical information of patients with PSC or IgG4-SC in Japan.

Management information
Registered date
2015 Year 07 Month 27 Day
Last modified on
2018 Year 02 Month 05 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000021349